Baculovirus Vector Stabilization for Multi-Passage rAAV Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing baculovirus vectors (rBVs) used for producing recombinant adeno-associated virus (rAAV) in insect cells become unstable during continuous passages, leading to decreased yield and unsuitability for large-scale production.
Innovation Solution
Incorporating a conserved noncoding element (CNE) or nucleocapsid assembly-essential element (NAE) sequence within 5 kb of the exogenous gene expression cassette in the baculovirus vector to stabilize the production of rAAV, ensuring the vector's stability during multiple passages.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional baculovirus vectors are used for rAAV production in insect cells, then the production system avoids mammalian cell limitations, but the vectors become unstable during continuous passages leading to decreased yield
Solution Approach 1:
The patent modifies the baculovirus vector by incorporating specific stable sequences (CNE or NAE) at defined positions relative to the exogenous gene expression cassette. This structural parameter change ensures the vector maintains stability during continuous passages while preserving high rAAV production capacity, resolving the contradiction between reliability and productivity
Solution Approach 2:
The patent introduces stable sequences (CNE or NAE) as intermediary elements that mediate between the exogenous gene expression cassette and the baculovirus genome. These intermediary sequences act as anchors to prevent gene loss during passages, thereby maintaining both vector stability and high rAAV yield simultaneously
2Ease of manufacture
If exogenous genes are integrated into baculovirus genomes through Tn7 transposons, then the system enables rAAV production, but the exogenous genes are easily lost during continuous passages
Solution Approach 1:
The patent applies preliminary action by pre-positioning stable sequences (CNE or NAE) adjacent to the exogenous gene expression cassette before integration into the baculovirus genome. This preliminary structural arrangement ensures that when the vector undergoes continuous passages, the exogenous genes are anchored and prevented from being lost, thus maintaining both ease of manufacture and genetic stability
Data Source
AI summary
A baculovirus vector and a use thereof in the preparation of a recombinant adeno-associated virus (rAAV) in an insect cell are provided. The baculovirus vector includes an exogenous gene expression cassette and a stable sequence. The stable sequence is located at a site 5 kb or less from the exogenous gene expression cassette, and the stable sequence is a conserved noncoding element (CNE) sequence or a nucleocapsid assembly-essential element (NAE) sequence. When an insect cell is infected with a recombinant baculovirus (rBV) constructed in this way, after multiple continuous passages, production levels of the rBV and the rAAV still remain relatively stable.